収縮期高血圧(Systolic Hypertension):治療薬開発パイプライン動向2014

調査会社DelveInsight社が発行したリサーチレポート(データ管理コード:DELVE41017685)
◆英語タイトル:Systolic Hypertension-Pipeline Insights, 2014
◆発行会社/調査会社:DelveInsight
◆商品コード:DELVE41017685
◆発行日:2014年版(※最新版はお問い合わせください)
◆調査対象地域:グローバル
◆産業分野:製薬
◆ページ数:60以上
◆レポート言語:英語
◆レポート形式:PDF
◆納品方式:Eメール(納品まで約3営業日)
◆販売価格オプション(消費税別)
Single User(1名使用)USD1,250 ⇒換算¥138,750見積依頼/購入/質問フォーム
Site Price(同一国内共有可)USD2,500 ⇒換算¥277,500見積依頼/購入/質問フォーム
Enterprise Price(複数国内共有可)USD4,000 ⇒換算¥444,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
DelveInsight社の概要及び新刊レポートはこちらでご確認いただけます。

★グローバルリサーチ資料[収縮期高血圧(Systolic Hypertension):治療薬開発パイプライン動向2014]についてメールでお問い合わせはこちら
本調査レポートでは、世界における収縮期高血圧(Systolic Hypertension)の治療薬開発パイプライン動向について調査・分析し、企業別開発中の治療薬、各臨床試験段階における製品リスト及び比較分析、薬剤候補のプロファイル、治療薬の評価、開発中止又は開発休止中の製品リスト等をお届けしています。また、収縮期高血圧(Systolic Hypertension)治療薬開発に取り組んでいる企業情報も提供しています。(※本レポートはご注文を頂いてから、最新データに更新して納品しているため、正確なページ数を明記しておりません。)

・収縮期高血圧(Systolic Hypertension)の概要

・収縮期高血圧(Systolic Hypertension)のパイプライン製品概要

・企業別開発中の治療薬

・後期治験段階の製品(Filed & Phase III):比較分析

・中期治験段階の製品(Phase II):比較分析

・初期治験段階の製品(Phase I & IND):比較分析

・前臨床段階の製品:比較分析

・薬剤候補のプロファイル

・収縮期高血圧(Systolic Hypertension)治療薬の評価
  - 単剤治療薬
  - 併用治療薬
  - 投与経路別
  - 分子の種類別

・開発が中止された製品リスト

・開発休止中の製品リスト

・収縮期高血圧(Systolic Hypertension)治療薬開発に取り組んでいる企業リスト

・図表一覧
*** レポート概要(サマリー)***

SUMMARY
DelveInsight’s,“ Systolic Hypertension-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish the understanding for all the pipeline drugs that fall under Systolic Hypertension. This report provides information on the therapeutic development based on the Systolic Hypertension dealing with all the pipeline drugs, comparative analysis at various stages covering Filed, Phase III, Phase II, Phase I, IND filed, Preclinical, Discovery and unknown stages, therapeutics assessment by monotherapy and combination products and molecule type drug information. The report also covers the companies information involved in the therapeutic development of the products. It also has highlighted the discontinued and dormant products.

[Data Sources]

The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by DelveInsight team of industry experts.

Secondary sources information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Magazines, Trade associations, Books, Industry Portals, Industry Associations and access to available databases.

Note*: This report requires certain updates. We have all the information available but require 3 business days to complete the process and ensure it is as up-to-date as possible. Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated Indication.


Scope
• The report provides a snapshot of the global therapeutic landscape of Systolic Hypertension
• The report provides pipeline products under drug profile section which includes product description, MOA, licensors & collaborators, development partner and chemical information
• Coverage of the Systolic Hypertension pipeline on the basis of target, MOA, route of administration, technology involved and molecule type
• The report reviews key players involved in the therapeutics development for Systolic Hypertension and also provide company profiling
• The report also gives the information of dormant and discontinued pipeline projects
• Pipeline products coverage based on various stages of development ranging from preregistration till discovery and undisclosed stages
• Provides pipeline assessment by monotherapy and combination therapy products, stage of development and molecule type


Reasons to buy
• Complete Pipeline intelligence and complete understanding over therapeutics development for Systolic Hypertension
• Identify the relationship between the drugs and use it for target finding, drug repurposing, and precision medicine.
• Devise corrective measures for pipeline projects by understanding Systolic Hypertension pipeline depth and focus of Indication therapeutics
• Developing strategic initiatives to support your drug development activities.
• Optimize your portfolio and keep you in touch with the rapidly changing pharmaceutical markets, and make the best decisions for your business.
• Develop and design in licensing and out licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
• Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies
• Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline
• Gaining a Full Picture of the Competitive Landscape for Evidence based Decisions


*** レポート目次(コンテンツ)***

Table of Contents
• Systolic Hypertension Overview
• Systolic Hypertension Pipeline Therapeutics
• Systolic Hypertension Therapeutics under Development by Companies
• Systolic Hypertension Late Stage Products (Filed and Phase III)
– Comparative Analysis
• Systolic Hypertension Mid Clinical Stage Products (Phase II)
– Comparative Analysis
• Systolic Hypertension Early Clinical Stage Products (Phase I and IND Filed)
– Comparative Analysis
• Systolic Hypertension Discovery and Pre-Clinical Stage Products
– Comparative Analysis
• Drug Candidate Profiles
• Systolic Hypertension – Therapeutics Assessment
– Assessment by Monotherapy Products
– Assessment by Combination Products
– Assessment by Route of Administration
– Assessment by Molecule Type
• Systolic Hypertension – Discontinued Products
• Systolic Hypertension – Dormant Products
• Companies Involved in Therapeutics Development for Systolic Hypertension
• Appendix
• Methodology
• Contact Us
• Disclaimer

List of Tables
• Number of Products under Development for Systolic Hypertension, 2014
• Number of Products under Development by Companies
• Comparative Analysis by Late Clinical Stage Products (Filed and Phase III), 2014
• Comparative Analysis Mid Clinical Stage Products (Phase II), 2014
• Comparative Analysis Early Clinical Stage Products (Phase I and IND Filed), 2014
• Comparative Analysis Discovery and Pre-Clinical Stage Products, 2014
• Drug Candidates Profiles
• Systolic Hypertension Assessment by Monotherapy Products
• Systolic Hypertension Assessment by Combination Products
• Systolic Hypertension Assessment by Route of Administration
• Systolic Hypertension Assessment by Stage and Route of Administration
• Systolic Hypertension Assessment by Molecule Type
• Systolic Hypertension Assessment by Stage and Molecule Type
• Systolic Hypertension Therapeutics – Discontinued Products
• Systolic Hypertension Therapeutics – Dormant Products
• Products under Development by Companies, 2014


List of Figures
• Number of Products under Development for Systolic Hypertension, 2014
• Late Clinical Stage Products (Filed and Phase III), 2014
• Mid Clinical Stage Products (Phase II), 2014
• Early Clinical Stage Products (Phase I and IND Filed), 2014
• Discovery and Pre-Clinical Stage Products, 2014
• Systolic Hypertension Assessment by Monotherapy Products
• Systolic Hypertension Assessment by Combination Products
• Systolic Hypertension Assessment by Route of Administration
• Systolic Hypertension Assessment by Stage and Route of Administration
• Systolic Hypertension Assessment by Molecule Type
• Systolic Hypertension Assessment by Stage and Molecule Type


*** レポートのキーワード ***

収縮期高血圧(Systolic Hypertension)、治療薬(医薬品、薬剤)、製薬企業、研究開発、治験、製品パイプライン

*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/


※おすすめ調査資料
  • 世界及び中国の移動杭打機市場2016
    The 'Global and Chinese Walking Pile Driver Industry, 2011-2021 Market Research Report' is a professional and in-depth study on the current state of the global Walking Pile Driver industry with a focus on the Chinese market. The report provides key statistics on the market status of the Walking Pile …
  • Respiratory Diseases in Spain 2014: Market Outlook and Emerging Opportunities
    [u]About This Report[/u]This new 281-page report from Venture Planning Group presents detailed analysis of the Spanish Respiratory Diseases market, including sales forecasts and supplier shares for Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV and Tuberculosis.  T …
  • チリのデビットカード市場動向
    This report is the result of Timetric’s extensive market research covering the debit cards market in Chile. It contains detailed data on market dynamics along with latest industry happenings, industry players in Chile. "Chile Debit Cards: Market Update" provides a top-level overview and detailed ins …
  • Rajkumar Forge Limited (513369):企業SWOT分析(エネルギー業界)
    Summary This comprehensive SWOT profile of Rajkumar Forge Limited provides you with an in-depth strategic analysis of the company's businesses and operations. The profile will give you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and thre …
  • フミン酸ナトリウムの世界市場
    Sodium Humate Report by Material, Application, and Geography – Global Forecast to 2021 is a professional and in-depth research report on the world's major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United States, Germany, …
  • 家庭用暖房器具(電気蓄熱暖房機、ヒーター など)市場規模、動向及び予測(~2018):ヨーロッパ
    This industry report package offers the most up-to-date market data on the actual market situation, trends, and future outlook for domestic heating appliances in different European countries. The package includes domestic heating appliance country reports from the following countries: Armenia, Austr …
  • 軟水装置の世界市場:メーカー別、地域別、種類別、用途別、市場予測(~2021)
    Water Hardness Removal is the device to remove of calcium, magnesium, and certain other metal cations in hard water. We statistics the equipment and system of specially used in water hardness removal in this report. Scope of the Report: This report focuses on the Water Hardness Removal in Global mar …
  • 世界の特殊カーボンブラック市場2017
    Notes:Sales, means the sales volume of Specialty Carbon Black Revenue, means the sales value of Specialty Carbon Black This report studies sales (consumption) of Specialty Carbon Black in Global market, especially in United States, China, Europe and Japan, focuses on top players in these regions/cou …
  • 1,2ヘキサンジオールの世界市場2015
    1,2 Hexanediol (CAS 6920-22-5) Market Research Report 2015 aims at providing comprehensive data on 1,2 Hexanediol market globally and regionally (Europe, Asia, North America, Latin America etc.) The report includes 1,2 Hexanediol description, covers its application areas, manufacturing methods, pate …
  • Brooks + Scarpa Architects – 企業概要
    WMI's 'Brooks + Scarpa Architects - Company Capsule' is a crucial resource for industry executives and anyone looking to access key information about 'Brooks + Scarpa Architects'. WMI's 'Brooks + Scarpa Architects - Company Capsule' report utilizes a wide range of primary and secondary sources, whic …
※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
※当市場調査資料(DELVE41017685 )"収縮期高血圧(Systolic Hypertension):治療薬開発パイプライン動向2014" (英文:Systolic Hypertension-Pipeline Insights, 2014)はDelveInsight社が調査・発行しており、H&Iグローバルリサーチが販売します。


◆H&Iグローバルリサーチのお客様(例)◆


※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
※H&Iグローバルリサーチ(登録第5864124号)及びH&I(登録第5783645号)はH&Iグローバルリサーチ株式会社の商標です。